Page tree

Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.


HTML
<script>
AJS.toInit(function(){
	if (AJS.params.remoteUser == ''){
		if (AJS.$("div.ia-fixed-sidebar").width() > 55){
			AJS.Confluence.Sidebar.toggle();
		}		
		AJS.$(".ia-fixed-sidebar").hide();		
	}
});
</script>


Alert
titleAbout this site
typeInfo

This site is intended for healthcare professionals seeking information on the CMS/HRSA-sponsored End Stage Renal Disease Treatment Choices Learning Collaborative.  If you are a patient seeking information on a kidney transplant click HERE.


Section


Column
width65%


Background Color
color#254878


End Stage Renal Disease Treatment Choices Learning Collaborative








In July 2019, an Executive Order was signed to launch the Advancing American Kidney Health (AAKH) initiative to transform the way we prevent and treat kidney disease. To accomplish the goals of the AAKH initiative, the Centers for Medicare & Medicaid Services (CMS) created the End Stage Renal Disease (ESRD) Treatment Choices (ETC) payment model to encourage preventative kidney care, home dialysis, and kidney transplants.

 

To support the ETC model’s focus on increased kidney transplants, CMS, in collaboration with the Health Resources & Services Administration (HRSA), has established the ESRD Treatment Choices Learning Collaborative (ETCLC). The ETCLC will bring transplant centers, Organ Procurement Organizations (OPOs), donor hospitals, patients, and families together to to improve quality and generate cost savings to CMS using systematic quality and process improvement methods.

 

This work will be supported by a National Faculty and Leadership Coordinating Council made up of more than 20 organizations in the field. To learn more, scroll down.


Section

Frequently Asked Questions


Section

Want to learn more? Email TAQILINFO@HSAG.COM

Want to enroll in the Collaborative? Click below.



View file
nameETCLC Committment for Results 10.27.21_fillable.pdf
height250







Section
bordertrue

NATIONAL AIMS

Over a 5-year period, the End Stage Renal Disease Treatment Choices Learning Collaborative intends to achieve the following national aims:


Column

AIM 1

Increase the number of deceased donor kidneys transplanted by 15%.


Column

AIM 2

Decrease the current national discard rate of all procured kidneys by 5%.


Column

AIM 3

Increase the utilization of high KDPI kidneys recovered (60-85 KDPI Score) by 14%.




Section


Column





Section


Background Color
color#E8DED1


Column

U.S. KIDNEY FACTS

  • 1 in 3 Americans are at risk for kidney disease.

  • 37 million people have chronic kidney disease.

  • 660,000 people live with kidney failure.

  • 100,000 people are waiting for a kidney.

            Source: National Kidney Foundation








Section




Section



Column



Column



Background Color
color#254878


Organizations

participating

Participating in ETCLC



Click below to see which organizations have enrolled in the ETCLC as of 04/30/2022.  





Section
bordertrue


Column

Organ Procurement Organizations




Section
bordertrue


Column

Transplant Centers





Section
bordertrue


Column

Donor Hospitals






Section
bordertrue


Column

National Faculty

Meet the National Faculty

National Faculty provide subject matter expertise to advise ETCLC participants throughout the improvement process. Led by two national chairs, members of the National Faculty represent transplant nephrologists and surgeons, Organ Procurement Organization professionals, donor hospitals, data analysts and statisticians, and patients.




Section
bordertrue


Column

Leadership Coordinating Council

Meet the National Coordinating Council

The Leadership Coordinating Council is a group of national stakeholders that guide the ETCLC.  Members represent the patient and professional organizations across the kidney community.





...